BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2943914)

  • 1. [Clinical tests on the diagnosis of thrombosis].
    Yamanaka M
    Nihon Rinsho; 1986 May; 44(5):1076-80. PubMed ID: 2943914
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular marker for hemostasis and thrombosis].
    Fukutake K; Fujimaki M
    Nihon Rinsho; 1989 Apr; 47(4):883-90. PubMed ID: 2664266
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasmatic markers of haemostatic system activation in patients with solid neoplasms.
    Sagripanti A; Carpi A; Ferdeghini M; Baicchi U; Grassi B
    J Nucl Med Allied Sci; 1990; 34(4):321-32. PubMed ID: 2151044
    [No Abstract]   [Full Text] [Related]  

  • 4. [New clinical tests in diagnosis of hematologic diseases].
    Nakahara K
    Nihon Naika Gakkai Zasshi; 1993 Apr; 82(4):529-33. PubMed ID: 8340662
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.
    Hughes RD; Lane DA; Ireland H; Langley PG; Gimson AE; Williams R
    Clin Sci (Lond); 1985 Jun; 68(6):701-7. PubMed ID: 2485273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of fibrinopeptide A and B beta 15-42 analysis in blood coagulo-fibrinolytic tests].
    Koshihara K; Fuzimaki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():889-91. PubMed ID: 2622023
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrinopeptide A (FPA), fibrinopeptide B (FPB) and fibrinopeptide Bbeta(15-42) (FPBbeta15-42)].
    Uchiba M; Okajima K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():615-7. PubMed ID: 15658404
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
    Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
    Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
    Walenga JM; Fareed J; Hoppensteadt D
    Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinogen proteolysis and platelet alpha-granule release in preeclampsia/eclampsia.
    Borok Z; Weitz J; Owen J; Auerbach M; Nossel HL
    Blood; 1984 Mar; 63(3):525-31. PubMed ID: 6230118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma fibrinopeptide A and fibrinopeptide B beta 15-42 levels in patients with Behçet's disease].
    Sunakawa M; Arai I; Okinami S
    Nippon Ganka Gakkai Zasshi; 1986 Jun; 90(6):871-4. PubMed ID: 3751789
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma concentrations of fibrinopeptide A, fibrinogen fragment B beta 1-42 and beta-thromboglobulin following total hip replacement.
    Lane DA; Ireland H; Wolff S; Grant R; Jennings S; Allen-Mersh T
    Thromb Res; 1982 Apr; 26(2):111-8. PubMed ID: 6180501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies.
    Papp AC; Hatzakis H; Bracey A; Wu KK
    Thromb Haemost; 1989 Feb; 61(1):15-9. PubMed ID: 2526384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prethrombotic state.
    Sixma JJ
    Br J Haematol; 1980 Dec; 46(4):515-22. PubMed ID: 6449215
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease.
    Nichols AB; Owen J; Kaplan KL; Sciacca RR; Cannon PJ; Nossel HL
    Blood; 1982 Sep; 60(3):650-4. PubMed ID: 6179552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever.
    Rao AK; Schapira M; Clements ML; Niewiarowski S; Budzynski AZ; Schmaier AH; Harpel PC; Blackwelder WC; Scherrer JR; Sobel E
    N Engl J Med; 1988 Apr; 318(16):1021-8. PubMed ID: 2965302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular markers of hemostatic activation on coronary artery disease.
    Ulutin T; Sönmez H; Uçişik N; Süer S; Bayram C; Kökoglu E; Sultuybek G
    Thromb Res; 1997 Nov; 88(3):329-32. PubMed ID: 9526953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indices of fibrinogen proteolysis and platelet activation during the resolution of pulmonary embolism.
    Yudelman I
    Thromb Haemost; 1987 Feb; 57(1):11-6. PubMed ID: 2954258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers.
    Ito T; Tanouchi J; Kato J; Nishino M; Iwai K; Tanahashi H; Hori M; Yamada Y; Kamada T
    Angiology; 1997 Oct; 48(10):901-6. PubMed ID: 9342969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin and plasmin activity and platelet activation in the development of venous thrombosis.
    Owen J; Kvam D; Nossel HL; Kaplan KL; Kernoff PB
    Blood; 1983 Mar; 61(3):476-82. PubMed ID: 6218846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.